Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Escape from T-cell–targeting immunotherapies in acute myeloid leukemia
Jayakumar Vadakekolathu, Sergio Rutella
Blood (2023) Vol. 143, Iss. 26, pp. 2689-2700
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Targeting the innate immune system in pediatric and adult AML
Alicia Perzolli, Joost B. Koedijk, C. Michel Zwaan, et al.
Leukemia (2024) Vol. 38, Iss. 6, pp. 1191-1201
Open Access | Times Cited: 13
Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
Qinyuan Gong, Rongzhen Xu
Frontiers in Immunology (2025) Vol. 15
Open Access
Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Georgios Petros Barakos, Vasileios Georgoulis, Epameinondas Koumpis, et al.
Diseases (2025) Vol. 13, Iss. 1, pp. 19-19
Open Access
Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy
Katie Maurer, Cameron Y. Park, Shouvik Mani, et al.
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access
Clinical impact of donor telomere length after umbilical cord blood transplantation
Kazuki Nagao, Megumi Watanuki, Hidenori Hayashi, et al.
Cytotherapy (2025)
Closed Access
Upregulation of LSP1 in AML cells enhances AML resistance to sorafenib and promotes apoptosis in CD8+ T cells
Peng Xu, Qiuhui Jiang, Shanlin Fu, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114255-114255
Closed Access
Mutated DNMT3A creates a public HLADQ- binding neoantigen on acute myeloid leukemia
Dyantha I. van der Lee, Eva M. Argiro, Sebastiaan N. J. Laan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers
Yingfang Feng, Meng Gao, Xiyue Xu, et al.
European Journal of Cancer (2024) Vol. 213, pp. 115069-115069
Closed Access | Times Cited: 4
Novel immunotherapies in the treatment of AML: is there hope?
Marion Subklewe, Veit Bücklein, David A. Sallman, et al.
Hematology (2023) Vol. 2023, Iss. 1, pp. 691-701
Closed Access | Times Cited: 10
Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft versus Leukemia Response with Adoptive Cellular Therapy
Katie Maurer, Cameron Y. Park, Shouvik Mani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia
Joost B. Koedijk, Inge van der Werf, Livius Penter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysis
Xin Wu, Zhongguang Wu, Woding Deng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
T cell-mediated tumor killing sensitivity gene signature-based prognostic score for acute myeloid leukemia
Yiyun Pan, Fang‐Fang Xie, Wen Zeng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?
Swati Naik, Mireya Paulina Velasquez, Stephen Gottschalk
Haematologica (2024) Vol. 109, Iss. 6, pp. 1656-1667
Open Access | Times Cited: 1
Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia
Maierbiya Abulimiti, Zheng-yi Jia, Yun Wu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 8, pp. 2797-2826
Closed Access | Times Cited: 1
An integrated multi-omics investigation of W-NK1, a cytokine-primed non-engineered natural killer cell therapy product
Laura Arthur, Nitin Mahajan, Jayakumar Vadakekolathu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia
Joost B. Koedijk, Inge van der Werf, Livius Penter, et al.
Leukemia (2024) Vol. 38, Iss. 11, pp. 2332-2343
Open Access | Times Cited: 1
The influence of immune checkpoint blockade on the outcomes of allogeneic hematopoietic stem cell transplantation
Ya-Lei Hu, Yuxin Wang, Kyungji Min, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Single-cell transcriptomics reveals heterogeneity and prognostic markers of myeloid precursor cells in acute myeloid leukemia
Guanghua He, Lai Jiang, Xuancheng Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
T Cell-Mediated Tumor Killing Sensitivity Gene Signature-Based Prognostic Score For Acute Myeloid Leukemia
Yiyun Pan, Fang‐Fang Xie, Wen Zeng, et al.
Research Square (Research Square) (2024)
Open Access
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia
Farnaz Barneh, Joost B. Koedijk, Noa E. Wijnen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Editorial: Community series in the immune escape mechanism and novel immunotherapeutic strategies of leukemia, volume II
Yixiang Han, Qianping Li, Yicheng Tan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Subtype-specific HERV-K102 envelope is a novel serum immunosuppressive biomarker and therapeutic target of cancer
Rongzhen Xu, Qinyuan Gong, Mengyuan Li, et al.
Research Square (Research Square) (2024)
Open Access
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia
Farnaz Barneh, Joost B. Koedijk, Noa E. Wijnen, et al.
Haematologica (2024)
Open Access
Page 1 - Next Page

Scroll to top